Michael D Loberg - Net Worth and Insider Trading
Michael D Loberg Net Worth
The estimated net worth of Michael D Loberg is at least $4 Million dollars as of 2024-09-20. Michael D Loberg is the Director of Arqule Inc and owns about 132,142 shares of Arqule Inc (ARQL) stock worth over $3 Million. Michael D Loberg is also the Director of IGM Biosciences Inc and owns about 72,627 shares of IGM Biosciences Inc (IGMS) stock worth over $1 Million. Details can be seen in Michael D Loberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael D Loberg has not made any transactions after 2022-09-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael D Loberg
Michael D Loberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael D Loberg owns 3 companies in total, including IGM Biosciences Inc (IGMS) , Arqule Inc (ARQL) , and AMAG Pharmaceuticals Inc (AMAG) .
Click here to see the complete history of Michael D Loberg’s form 4 insider trades.
Insider Ownership Summary of Michael D Loberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IGMS | IGM Biosciences Inc | 2022-09-28 | director |
| ARQL | Arqule Inc | 2020-01-16 | director |
| AMAG | AMAG Pharmaceuticals Inc | 2008-12-19 | director |
Michael D Loberg Latest Holdings Summary
Michael D Loberg currently owns a total of 2 stocks. Among these stocks, Michael D Loberg owns 132,142 shares of Arqule Inc (ARQL) as of December 17, 2015, with a value of $3 Million and a weighting of 67.82%. Michael D Loberg also owns 72,627 shares of IGM Biosciences Inc (IGMS) as of September 28, 2022, with a value of $1 Million and a weighting of 32.18%.
Latest Holdings of Michael D Loberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARQL | Arqule Inc | 2015-12-17 | 132,142 | 20.00 | 2,642,840 |
| IGMS | IGM Biosciences Inc | 2022-09-28 | 72,627 | 17.27 | 1,254,268 |
Holding Weightings of Michael D Loberg
Michael D Loberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael D Loberg has made a total of 0 transactions in Arqule Inc (ARQL) over the past 5 years. The most-recent trade in Arqule Inc is the acquisition of 3,719 shares on December 17, 2015, which cost Michael D Loberg around $8,033.
According to the SEC Form 4 filings, Michael D Loberg has made a total of 2 transactions in IGM Biosciences Inc (IGMS) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in IGM Biosciences Inc is the acquisition of 6,679 shares on September 28, 2022, which cost Michael D Loberg around $139,524.
Insider Trading History of Michael D Loberg
- 1
Michael D Loberg Trading Performance
GuruFocus tracks the stock performance after each of Michael D Loberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael D Loberg is -9.21%. GuruFocus also compares Michael D Loberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael D Loberg within 3 months outperforms 15 times out of 44 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael D Loberg's insider trading performs compared to the benchmark.
Performance of Michael D Loberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.8 | | | | | |
| Relative Return to S&P 500(%) | -0.6 | | | | | |
Michael D Loberg Ownership Network
Michael D Loberg Owned Company Details
What does IGM Biosciences Inc do?
Who are the key executives at IGM Biosciences Inc?
Michael D Loberg is the director of IGM Biosciences Inc. Other key executives at IGM Biosciences Inc include Principal Accounting Officer Steven Weber , Chief Medical Officer Chris H Takimoto , and Chief Financial Officer Misbah Tahir .
IGM Biosciences Inc (IGMS) Insider Trades Summary
Over the past 18 months, Michael D Loberg made no insider transaction in IGM Biosciences Inc (IGMS). Other recent insider transactions involving IGM Biosciences Inc (IGMS) include a net sale of 37,229 shares made by Fred Schwarzer , a net sale of 16,027 shares made by Bruce Keyt , and a net sale of 12,086 shares made by Lisa Lynn Decker .
In summary, during the past 3 months, insiders sold 26,420 shares of IGM Biosciences Inc (IGMS) in total and bought 0 shares, with a net sale of 26,420 shares. During the past 18 months, 193,169 shares of IGM Biosciences Inc (IGMS) were sold and 1,130,933 shares were bought by its insiders, resulting in a net purchase of 937,764 shares.
IGM Biosciences Inc (IGMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
IGM Biosciences Inc Insider Transactions
Michael D Loberg Mailing Address
Above is the net worth, insider trading, and ownership report for Michael D Loberg. You might contact Michael D Loberg via mailing address: C/o Arqule, Inc., 1 Wall Street, 6th Floor, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
